Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
02/24/2009 | US7495086 TWEAK receptor |
02/24/2009 | US7494978 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
02/24/2009 | US7494977 Polypeptides homologous to VEGF and BMP1 |
02/24/2009 | US7494813 VAC-BAC shuttle vector system |
02/24/2009 | US7494810 Method for accessing microbial diversity |
02/24/2009 | US7494801 Method of selecting Escherichia coli strain which highly expresses exogenous genes, Escherichia coli mutant strains selected by this method and process for producing enzymes and compounds using the same |
02/24/2009 | US7494800 Which transfer N-acetylgalactosamine to N-acetylglucosamine via beta 1-4 linkage; host cells |
02/24/2009 | US7494796 Site directed mutagenesis; orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases; cells |
02/24/2009 | US7494792 Process for the production of cellulolytic and hemicellulolytic enzymes using distillation residues from the ethanolic fermentation of enzymatic hydrolyzates of (ligno)cellulosic materials |
02/24/2009 | US7494786 Genetically engineered nuclear inclusion proteinase (NIa) comprising increased stability for obtaining large quantities of purified active proteins that form inclusion bodies in cells; modifying enzyme for premature polypeptides |
02/24/2009 | US7494774 Assay and compositions for detection of Bacillus anthracis nucleic acid |
02/24/2009 | US7494771 A rapid (10 to 15 minutes), simple, flexible and efficient method of nucleic acids extraction for nucleic acid testing assays |
02/24/2009 | US7494657 Inhibitor of hepatitis B and HIV activity |
02/24/2009 | US7494655 antigenic peptides, antibodies and carriers, diluents, excipients, adjuvants or auxiliary agents, use for inhibiting the formation of beta-amyloid; treatment of Alzheimer's disease or Down's syndrome |
02/24/2009 | US7494653 Inoculating a patient with an effective amount of PcrV antigen; monoclonal antibodies specific for the PcrV antigen |
02/24/2009 | US7494645 proteins comprising an amino acid sequence including the catalytic region and regulatory domains; the protein inhibits neurite retraction in an (lysophosphatidic acid) LPA-induced neurite retraction bioassay; used for treating nervous system disorders and/or injuries |
02/24/2009 | CA2414978C Preparation of a recombinant protein in a prokaryotic host cell |
02/24/2009 | CA2396250C Mutant apre promoter |
02/24/2009 | CA2334919C Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects |
02/24/2009 | CA2278892C A method for the production of dicarboxylic acids |
02/24/2009 | CA2195542C Culture medium for rapid count of coliform bacteria |
02/24/2009 | CA2194571C Novel amylolytic enzymes derived from the b. licheniformis .alpha.-amylase, having improved characteristics |
02/19/2009 | WO2009023493A1 Methods and organisms for the growth-coupled production of 1,4-butanediol |
02/19/2009 | WO2009023308A2 Genetically modified babesia parasites expressing protective tick antigens and uses thereof |
02/19/2009 | WO2009023270A2 Compositions and methods for modifying properties of biologically active polypeptides |
02/19/2009 | WO2009022755A1 METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY WITH ATTENUATED EXPRESSION OF THE chaC GENE |
02/19/2009 | WO2009022754A1 METHOD FOR PRODUCING L-AMINO ACID USING BACTERIUM OF ENTEROBACTERIACEAE FAMILY, HAVING ATTENUATED EXPRESSION OF THE yahN GENE |
02/19/2009 | WO2009022399A1 Novel microorganism having gastric juice promoting action and composition secreted by the same |
02/19/2009 | WO2009021977A1 Human specific escherichia coli strains |
02/19/2009 | WO2009021853A1 Eukaryotic promoters for gene expression |
02/19/2009 | WO2009021399A1 Biotoxin adsorbent and its producing process |
02/19/2009 | WO2008155781A8 Golden yellow algae and method of producing the same |
02/19/2009 | WO2008143630A3 Recombinant hydrogen-producing cyanobacterium and uses thereof |
02/19/2009 | WO2008115958A3 Materials and methods for efficient succinate and malate production |
02/19/2009 | WO2006052914A3 Diacylglycerol acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
02/19/2009 | US20090048434 Compositions and methods relating to orthogonal ribosome mRNA pairs |
02/19/2009 | US20090048330 Compound from Antrodia camphorata and the use thereof |
02/19/2009 | US20090048324 Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules |
02/19/2009 | US20090048176 Antibacterial agent |
02/19/2009 | US20090048163 Nucleic acid and protein sequences of asporins |
02/19/2009 | US20090048161 Cytokine receptor modulators and uses thereof |
02/19/2009 | US20090048160 Antimicrobial activity of bovine bactericidal/permeability-increasing protein (BPI)-derived peptides against Gram-negative bacterial mastitis isolates |
02/19/2009 | US20090048136 Kappa-carrageenase and kappa-carrageenase-containing compositions |
02/19/2009 | US20090047736 Human T1R2 nucleic acid sequences and polypeptides |
02/19/2009 | US20090047730 Methods for Controlling Dust and Creating Bio-Crust |
02/19/2009 | US20090047729 Transport media |
02/19/2009 | US20090047722 Systems, devices, and methods for biomass production |
02/19/2009 | US20090047719 Methods and organisms for the growth-coupled production of 1,4-butanediol |
02/19/2009 | US20090047718 Methods and compositions for producing solvents |
02/19/2009 | US20090047710 ST3Gal-1/ST6GalNAc-1 Chimeras |
02/19/2009 | US20090047709 Novel endoribonuclease |
02/19/2009 | US20090047708 Highly productive recombinant yeast strains with modified galactose-regulated transcription |
02/19/2009 | US20090047707 Bacterial recombinant phytase |
02/19/2009 | US20090047706 Process for producing dipeptides |
02/19/2009 | US20090047705 Microorganism-derived psychrophilic endonuclease |
02/19/2009 | US20090047701 Method for screening antifungal agents |
02/19/2009 | US20090047387 Protease variants |
02/19/2009 | US20090047384 Lipolytic enzyme variants |
02/19/2009 | US20090047381 Ammonia transporter gene and use thereof |
02/19/2009 | US20090047380 Catalase gene and use thereof |
02/19/2009 | US20090047339 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
02/19/2009 | US20090047335 Anti-angiogenic peptides and methods of use thereof |
02/19/2009 | US20090047293 immunization; comprised of a fusion protein; bioterrorism; plague |
02/19/2009 | US20090047283 Compounds and methods for treatment and diagnosis of chlamydial infection |
02/19/2009 | US20090047253 Probiotic system for aquaculture |
02/19/2009 | CA2695706A1 Methods and organisms for the growth-coupled production of 1,4-butanediol |
02/18/2009 | EP2025760A1 Method of producing hydroxycarboxylic acid by regenerating coenzyme |
02/18/2009 | EP2025759A1 Method for production of hydroxycarboxylic acid by enhancing the synthesis of coenzyme |
02/18/2009 | EP2025754A2 Moraxella (Branhamella) catarrhalis antigens |
02/18/2009 | EP2025749A1 Humanized anti-human osteopontin antibody |
02/18/2009 | EP2025682A2 Human endokine alpha |
02/18/2009 | EP2025620A1 Active packaging that inhibits food pathogens |
02/18/2009 | EP2024491A2 Production of fatty acids and derivatives thereof |
02/18/2009 | EP2024490A2 Novel chlorella species and uses therefor |
02/18/2009 | EP2024489A1 Process for the production of yeast |
02/18/2009 | EP2023962A2 Human oct-2 variant peptide chains, nucleic acids, and methods |
02/18/2009 | EP1329503B1 Sphingolipid ceramide deacylase gene |
02/18/2009 | EP1249494B1 Process for the biological production of l-pipecolic acid |
02/18/2009 | EP1196447B1 Method for stabilising proteins in complex mixtures during their storage in aqueous solvents |
02/18/2009 | EP1071955B2 Improved immunodiagnostic assays using reducing agents |
02/18/2009 | EP1023439B1 alpha-AMYLASE MUTANTS |
02/18/2009 | CN101370936A DNA modular cloning vector plasmids and methods for their use |
02/18/2009 | CN101370932A Lactic acid-producing yeast cells having nonfunctional L-or D-lactate: ferricytochrome C oxidoreductase gene |
02/18/2009 | CN101370929A Thraustochytrium strain-SC1 for producing Docosahexaenic Acid |
02/18/2009 | CN101368169A Pseudomonas putida for preparing deoxidized violacein and uses thereof |
02/18/2009 | CN101368168A Method for preparing (S)-styrene glycol with carbonyl reduction enzyme and pyrimidine nucleoside acid transhydrogenase couplet |
02/18/2009 | CN101368167A Recombinant lactobacillus casei for co-expression of swine fever virus T cell epitope and pig parvoviral VP2 protein, and method of producing the same |
02/18/2009 | CN101368166A Method for preparing oligomycin A and special for bacterial strain thereof |
02/18/2009 | CN101368165A Probiotic composition for livestock and poultry |
02/18/2009 | CN101368164A Combined cholate hydrolysis enzyme gene and lactobacillus casei comprising the gene |
02/18/2009 | CN101368163A Pichia engineering bacterial strain for expression of thermosacus aurantiancus miehe light spore variation gene Mn-sod |
02/18/2009 | CN101368162A Composite yeast suitable for sugariness raw material high concentration alcoholic fermentation |
02/18/2009 | CN101368161A Preparation method for inonotus obliquus pedigree seed culture medium |
02/18/2009 | CN101368160A Preparation method for inonotus obliquus production of seed culture medium |
02/18/2009 | CN101368159A Preparation method for inonotus obliquus mother seed culture medium |
02/18/2009 | CN101368158A Preparation method for birch fuscoporia ferrugineo-fusca teng submerged fermentation culture medium |
02/18/2009 | CN101368157A Quick bacteria cell cracking agent prescription |
02/18/2009 | CN101368154A Continuous culture system and method for human intestinal canal flora |
02/18/2009 | CN101367869A Polypeptide for preventing, diagnosing and treating hepatitis E virus, and vaccine as diagnosis agent of the same |
02/18/2009 | CN101367001A Methods of using transformed plants expressing plant-derived acyl-coenzyme-A-binding proteins in phytoremediation |